Vaccine using microneedle patch with RSV virus, immune-stimulating compound is effective against RSV

This is the photomicrographic detection of respiratory syncytial virus (RSV) using indirect immunofluorescence technique. Credit: Public Domain Picture Skin vaccination using a microneedle patch that contains the inactivated respiratory syncytial virus (RSV) and a compound that stimulates immune responses to the virus has been found to enhance protection against this serious disease and reduce inflammation in the body after exposure to the virus, according to a study led by Georgia State University. The findings, published in the journal PLOS ONE, describe a promising, effective RSV vaccine and delivery method, which was tested in mice. There are no approved vaccines to protect against this disease. RSV is a common respiratory disease, but it can be serious for young children, patients with compromised immune systems and elderly people. For children under 1 year old in the United States, RSV is the most common cause of bronchiolitis, inflammation of the small airways in the lung and...